Return to search

Bridgepoint sells Quotient for £165m

The sale to specialist healthcare investor GHO Capital nets the firm a 6.4x multiple.

Private equity firm Bridgepoint has sold UK drug development services company Quotient Clinical to specialist healthcare investor GHO Capital for a deal value understood to be around £165 million (€233 million; $247 million). Bridgepoint has held the for less than two years, and the exit is believed to represent an internal rate of return of 178 percent and a profit of 6.4 times the amount invested.

Read the full article by visiting Private Healthcare Investor.